Skip to content

Clinical trials

Tobacco Use Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tobacco Use Disorder Country / region: United States Clear all

798 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20019
200213
200315
200420
200533
200625
200730
200832
200954
201031
201141
201240
201336
201428
201541
201631
201726
201840
201928
202029
202137
202224
202321
202434
202523
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed612
Recruiting61
Terminated41
Withdrawn28
Unknown status22
Active, not recruiting17
Not yet recruiting10
Enrolling by invitation4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)65
Yale University57
University of Pennsylvania36
University of California, San Francisco32
University of Minnesota30
Medical University of South Carolina28
Duke University26
University of Wisconsin, Madison25
Mayo Clinic24
Massachusetts General Hospital22

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tobacco Use Disorder798
Substance-Related Disorders39
Alcoholism27
Schizophrenia25
Lung Neoplasms21
Carcinoma, Non-Small-Cell Lung14
Head and Neck Neoplasms12
Marijuana Abuse12
Mental Disorders10
Small Cell Lung Carcinoma10

Trials

Showing 1 to 25 of 798. Each trial links to its page on Pharma Observatory.

698 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.